Suven Pharmaceuticals Ltd
NSE:SUVENPHAR

Watchlist Manager
Suven Pharmaceuticals Ltd Logo
Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Watchlist
Price: 1 259.15 INR -2.18% Market Closed
Market Cap: 320.5B INR
Have any thoughts about
Suven Pharmaceuticals Ltd?
Write Note

Suven Pharmaceuticals Ltd
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Suven Pharmaceuticals Ltd
Short-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Short-Term Investments
â‚ą7.8B
CAGR 3-Years
62%
CAGR 5-Years
144%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Short-Term Investments
â‚ą76.7B
CAGR 3-Years
53%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Short-Term Investments
â‚ą77.9B
CAGR 3-Years
40%
CAGR 5-Years
36%
CAGR 10-Years
18%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Short-Term Investments
â‚ą117.4B
CAGR 3-Years
44%
CAGR 5-Years
21%
CAGR 10-Years
22%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Short-Term Investments
â‚ą3.3B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
6%
M
Mankind Pharma Ltd
NSE:MANKIND
Short-Term Investments
â‚ą30B
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Suven Pharmaceuticals Ltd
Glance View

Market Cap
320.5B INR
Industry
Pharmaceuticals

Suven Pharmaceuticals Ltd. manufactures chemical products. The company is headquartered in Hyderabad, Telangana and currently employs 1,193 full-time employees. The company went IPO on 2020-03-09. The firm operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe and Rest of the World. In India, the Company sells bulk drugs and intermediates, fine chemicals and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In Rest of the World, the Company sells bulk drugs, intermediates and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.

SUVENPHAR Intrinsic Value
402.41 INR
Overvaluation 68%
Intrinsic Value
Price

See Also

What is Suven Pharmaceuticals Ltd's Short-Term Investments?
Short-Term Investments
7.8B INR

Based on the financial report for Mar 31, 2024, Suven Pharmaceuticals Ltd's Short-Term Investments amounts to 7.8B INR.

What is Suven Pharmaceuticals Ltd's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
144%

Over the last year, the Short-Term Investments growth was 84%. The average annual Short-Term Investments growth rates for Suven Pharmaceuticals Ltd have been 62% over the past three years , 144% over the past five years .

Back to Top